CD133-Expressing Stem Cells Associated with Ovarian Metastases Establish an Endothelial Hierarchy and Contribute to Tumor Vasculature
- 1 March 2009
- journal article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 27 (3), 498-508
- https://doi.org/10.1634/stemcells.2008-0868
Abstract
Recruitment and localization of endothelial precursors within tumors is a potential area for the development of therapeutics, because their functional contribution to tumor vasculature is realized to be important for cancer cell survival. However, the exact nature of the recruited cell type and cellular events orchestrating the entire phenomenon remains obscure. We report that human ovarian cancer is frequently associated with cells expressing the stem cell surface marker CD133. We further show that these CD133-expressing cells are nontumorigenic in nature, and they augment tumor development through their vasculogenic potential. This cell population is attracted by cancer stem cells (CSCs) and retains a direct physical association within the CSC-derived spheroids. Our study further delineates the contribution of these vasculogenic CD133+ stem cells, termed by us as endothelial stem cells (EnSCs) to the developing tumor vasculature during disease progression. In support of their being stem cells, the EnSCs have a capability of establishing an entire endothelial cell hierarchy. We conclude that such EnSCs play a crucial role in ensuring the development of long-term tumor vasculature to complement CSC-driven tumor development and disease progression.Keywords
This publication has 41 references indexed in Scilit:
- Identification and expansion of the tumorigenic lung cancer stem cell populationCell Death & Differentiation, 2007
- Identification and Characterization of Tumorigenic Liver Cancer Stem/Progenitor CellsGastroenterology, 2007
- CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicityInternational Journal of Cancer, 2007
- Identification and expansion of human colon-cancer-initiating cellsNature, 2006
- Prospective Identification of Tumorigenic Prostate Cancer Stem CellsCancer Research, 2005
- The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumorsInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Identification of human brain tumour initiating cellsNature, 2004
- Endothelial Progenitor CellsCirculation Research, 2004
- Stem cells, cancer, and cancer stem cellsNature, 2001
- The Human AC133 Hematopoietic Stem Cell Antigen Is also Expressed in Epithelial Cells and Targeted to Plasma Membrane ProtrusionsJournal of Biological Chemistry, 2000